Care

Epigenetic profiling creates opportunities for healthcare and the development of new drugs based on it, according to Mohamad Takwa, CEO of Epigenica, a Sweden-based company that focuses on the technology.

In a post on LinkedIn, Color CEO Othman Laraki said the company would focus on its core lines of business, including testing and telehealth infrastructure for government programs, and its prevention tools for employers and healthcare purchasers.

Also, EpiSoft announces the integration of its cancer management platform with My Health Record.

In a proposed order, the online therapy company would also pay $7.8 million for allegedly sharing consumer data with third parties like Facebook and Snapchat for advertising purposes.

The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.

Taghreed Justinia, regional director for IT services at King Saud bin Abdulaziz University for Health Sciences, explains how the G20 Riyadh declaration aligned recommendations with the WHO's Global Strategy on Digital Health.

The wearable uses its motion sensors to determine if the user has taken a hard fall and can contact emergency services if they don't respond.

Wolters Kluwer Health CMO Dr. Peter Bonis discusses what was learned from donating UpToDate to middle- and low-income countries, including how access to evidence-based clinical guidance can reduce barriers, regardless of setting.

DenovAI will create an AI-powered platform to discover potential antibodies from scratch, then suggest which ones can be used as effective drugs.

The company reported $526.9 million in revenue last year compared with $271.9 million in 2021.